Exposure to airborne polycyclic aromatic hydrocarbons during pregnancy and risk of preterm birth

Amy M Padula1, Elizabeth M Noth2, S Katharine Hammond2

  • 1Stanford University, School of Medicine, Department of Pediatrics, Stanford, CA, USA.

Environmental Research
|October 6, 2014
PubMed

Insights

Exposure to polycyclic aromatic hydrocarbons (PAHs) in late pregnancy is linked to early preterm birth. This study investigated the association between PAH exposure and adverse birth outcomes in Fresno, California.

Area of Science:

  • Environmental Health
  • Reproductive Epidemiology
  • Toxicology

Background:

  • Preterm birth affects 12-13% of U.S. births, serving as a key health indicator.
  • Polycyclic aromatic hydrocarbons (PAHs) are contaminants from incomplete fuel combustion.
  • Prenatal PAH exposure is suspected to correlate with adverse birth outcomes.

Purpose of the Study:

  • To investigate the association between maternal exposure to polycyclic aromatic hydrocarbons (PAHs) during pregnancy and the incidence of preterm birth.
  • To quantify the risk of preterm birth associated with varying levels of PAH exposure.

Main Methods:

  • Utilized birth data from Fresno, California (2001-2006) within a 20km radius of a monitoring site.
  • Developed a spatio-temporal model to estimate daily PAH exposure (4-6 rings) at maternal residences throughout pregnancy.
  • Extracted gestational age and covariates from birth certificates.

Main Results:

  • An association was found between PAH exposure in the final 6 weeks of pregnancy and birth at 20-27 weeks (OR=2.74).
  • Higher quartiles of PAH exposure showed a dose-response relationship with early preterm birth.
  • Inverse associations were noted between overall pregnancy PAH exposure and later preterm birth categories (28-31 weeks).

Conclusions:

  • Maternal exposure to PAHs in the six weeks preceding delivery is associated with early preterm birth.
  • The observed inverse association between PAH exposure and early preterm birth suggests a complex relationship requiring further investigation.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
58
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
19